Newly Published: Microvesicles and Tumor Microenvironment in Cancer Development and Resistance to Therapies
Featured Article: Role of the NLRP3 inflammasome in cancer
In this review, Sahebkar et al. summarize the current knowledge on the contribution of the NLRP3 inflammasome on potential cancer promotion and therapy.
Thematic Series Published in 2018
Series of Review Articles: Oncogenic Signaling of Tyrosine Kinase in Cancer: Challenges and Therapeutic Opportunities
Editor-in-Chief
Christophe Nicot, Kansas University Medical Center, USA
Aims and scope
Molecular Cancer is an open access, peer-reviewed journal interested in attracting high-quality original research and reviews that present or highlight significant advances in all areas of cancer and related biomedical science.
Impact Factor
Molecular Cancer has an Impact Factor of 7.776 and is ranked in the top 10% of both its JCR Categories.
It is currently ranked at 27 out of 292 (Q1) in the Biochemistry and Molecular Biology category and 22 out of 222 (Q1) in the Oncology category of Journal Citation Reports.
Advertisement
Follow
Annual Journal Metrics
-
Speed
59 days to first decision for reviewed manuscripts only
49 days to first decision for all manuscripts
121 days from submission to acceptance
17 days from acceptance to publication
Citation Impact
7.776 - 2-year Impact Factor
6.335 - 5-year Impact Factor
1.682 - Source Normalized Impact per Paper (SNIP)
2.778 - SCImago Journal Rank (SJR)Usage
1,008,353 downloadsSocial Media Impact
352 mentions
Advertisement
